Trial Profile
A pilot study to determine the effect of celecoxib on markers of inflammation in patients with hypertension and coronary artery disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary)
- Indications Cardiovascular disorders
- Focus Pharmacodynamics
- 18 Jul 2007 New trial record.